BRAF and non-small cell lung carcinoma: In NSCLC, Asian patients were less likely to have Class 3 mutations (16%) and more likely to have BRAF fusions (19%) compared to Black patients (32% Class 3 and 4% Fusions) or White patients (30% Class 3 and 3% Fusions).